Sellbyville, DE -- (SBWIRE) -- 11/14/2018 -- The Tubeless Insulin Pump Market set to exceed USD 2 billion by 2024; according to a new research report by Global Market Insights, Inc. Escalating prevalence of diabetes and obesity, growing geriatric population and technological advances in tubeless insulin delivery should drive the market size. According to WHO, diabetes will be the among the leading causes of death by 2030. These factors will prominently intensify the global usage of tubeless insulin pump over the forecast period.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2032

Increased adoption of non-invasive transdermal insulin delivery systems has improved patient compliance for diabetes treatment. Use of microneedles and micro-emulsions improves permeation of insulin through transdermal route. Other effective routes of insulin administration such as oral, buccal, nasal is explored as alternative non-invasive modes of delivery.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
1. Abbott
2. Johnson & Johnson
3. Insulet Corporation
4. Medtrum Technologies Inc.
5. Cellnovo Group SA
6. Valeritas
7. Spring Health
8. Debiotech SA
9. CeQur

E-commerce held the largest market share in 2016 and will continue to be the biggest distribution channel for tubeless insulin pump over the forecast period. Its popularity should grow over coming years owing to rapid penetration of internet and ease of procurement from remote locations, the e-commerce will be the most popular channel for purchase of tubeless insulin pump.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2032

U.S. tubeless insulin pump market valued over USD 200 million in 2016 and anticipated to grow significantly over the coming years. Switching of insulin pump user from tubed to tubeless should be the major growth rendering factor. Moreover, increasing adoption of tubeless pump by first time users will fuel regional industry growth. Germany tubeless insulin pump market accounted for more than 20% of overall regional revenue share, owing to increasing number of diabetic patients and advanced healthcare system. Growing adoption of advanced technology will drive rapid industry grow over the forecast years.

Tubeless insulin Pump market by component
o Pod/Patch
o Remote

Tubeless insulin Pump market by distribution channel
o Hospitals
o Pharmacies
o E-commerce